BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,090 filers reported holding BAXTER INTL INC in Q2 2021. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,221,716 | -14.3% | 58,869 | +3.4% | 0.02% | -9.1% |
Q2 2023 | $2,592,774 | +10.8% | 56,909 | -1.4% | 0.02% | +4.8% |
Q1 2023 | $2,340,717 | -23.2% | 57,710 | -3.5% | 0.02% | -27.6% |
Q4 2022 | $3,049,484 | -5.7% | 59,829 | -0.3% | 0.03% | -14.7% |
Q3 2022 | $3,233,000 | -12.9% | 60,027 | +3.9% | 0.03% | -8.1% |
Q2 2022 | $3,710,000 | -16.7% | 57,766 | +0.5% | 0.04% | -5.1% |
Q1 2022 | $4,456,000 | -7.5% | 57,470 | +2.4% | 0.04% | +5.4% |
Q4 2021 | $4,816,000 | +9.4% | 56,109 | +2.5% | 0.04% | 0.0% |
Q3 2021 | $4,402,000 | +3.5% | 54,730 | +3.6% | 0.04% | 0.0% |
Q2 2021 | $4,252,000 | +1.0% | 52,824 | +5.8% | 0.04% | -11.9% |
Q1 2021 | $4,211,000 | +3.6% | 49,927 | -1.4% | 0.04% | -31.1% |
Q4 2020 | $4,064,000 | -32.0% | 50,647 | -31.8% | 0.06% | -39.6% |
Q3 2020 | $5,976,000 | +11.4% | 74,316 | +19.3% | 0.10% | -2.9% |
Q2 2020 | $5,363,000 | -16.0% | 62,289 | -20.8% | 0.10% | -36.2% |
Q1 2020 | $6,383,000 | +43.0% | 78,616 | +47.3% | 0.16% | +64.6% |
Q4 2019 | $4,464,000 | -10.9% | 53,386 | -6.8% | 0.10% | -19.5% |
Q3 2019 | $5,012,000 | -25.4% | 57,296 | -30.2% | 0.12% | -27.6% |
Q2 2019 | $6,723,000 | -10.1% | 82,090 | -10.7% | 0.17% | -14.1% |
Q1 2019 | $7,476,000 | +10.5% | 91,939 | -10.6% | 0.20% | -3.9% |
Q4 2018 | $6,767,000 | -15.0% | 102,814 | -0.5% | 0.21% | -3.7% |
Q3 2018 | $7,965,000 | -13.7% | 103,325 | -17.3% | 0.21% | -20.7% |
Q2 2018 | $9,231,000 | +29.1% | 125,013 | +13.8% | 0.27% | +21.1% |
Q1 2018 | $7,148,000 | +55.9% | 109,899 | +55.0% | 0.22% | +59.3% |
Q4 2017 | $4,586,000 | – | 70,918 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 41,000,000 | $2,482,140,000 | 22.00% |
THUNDERBIRD PARTNERS LLP | 1,711,643 | $103,623,000 | 12.17% |
SECTOR GAMMA AS | 1,070,333 | $64,798,000 | 9.42% |
Veritas Asset Management LLP | 10,179,102 | $616,243,000 | 4.81% |
13D Management LLC | 194,807 | $11,794,000 | 4.18% |
Progressive Investment Management Corp | 78,316 | $4,741,000 | 3.69% |
Aristotle Capital Management, LLC | 6,846,307 | $414,476,000 | 3.46% |
ARGENT CAPITAL MANAGEMENT LLC | 1,394,075 | $84,397,000 | 3.37% |
Lipe & Dalton | 80,073 | $4,848,000 | 3.14% |
PURA VIDA INVESTMENTS, LLC | 125,000 | $7,568,000 | 3.00% |